Joann Data

Since 2006, Dr. Data has been working as a drug development and regulatory affairs consultant in the biotechnology and pharmaceuticals industries. From 1999 – 2005, Dr. Data served as Senior Vice President of Regulatory Affairs and Quality Assurance for Amylin Pharmaceuticals (NASDAQ: AMLN).  Prior to her service at Amylin, Dr. Data served as Executive Vice President, Product Development and Regulatory Affairs at CoCensys. Prior to her employment with CoCensys, Dr. Data held several positions at The Upjohn Company, the most recent of which was Corporate Vice President for Worldwide Pharmaceutical Regulatory Affairs and Project Management. Previously, Dr. Data held a number of positions at Hoffman-La Roche, including Vice President of Clinical Research and Development. Dr. Data has been an adjunct assistant professor in medicine and pharmacology at Duke University Medical Center since 1982 and at Cornell Medical Center since 1986. Dr. Data earned her M.D. from Washington University School of Medicine and her Ph.D. in Pharmacology from Vanderbilt University.

Mountain Group Capital, LLC | 1600 Division Street, Suite 580, Nashville, TN 37203 | Phone: (615) 843-9100 | Fax: (615) 313-9996
Site Map